Histamine induces interleukin-8 secretion by endothelial cells

Blood. 1994 Oct 1;84(7):2229-33.

Abstract

It has been shown that histamine induces early changes on endothelial cells (EC), such as a transient expression of P-selectin and secretion and/or surface expression of early mediators (eg, prostacyclin [PG1(2)], platelet-activating factor [PAF], and leukotriene B4 [LTB4]). However, delayed effects of histamine on EC and particularly on cytokine production are undefined. In this study, the effect of histamine on interleukin (IL)-8 production by EC was evaluated using an enzyme-linked immunosorbent assay (ELISA) method and mRNA expression. The results showed that histamine increased the secretion and the mRNA expression of IL-8 by EC. Histamine-induced IL-8 production was (1) dose-dependent (at a dose > or = 10(-6) mol/L), (2) potentialized by costimulation with tumor necrosis factor (TNF)-alpha, (3) inhibited by H1 or H2 histamine receptor antagonists, and (4) significantly increased 4 hours after the initial stimulation. These data suggest that histamine may be involved in the control of the late inflammatory reaction associated to allergic disorders through IL-8 secretion by EC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Drug Synergism
  • Endothelium, Vascular / metabolism*
  • Gene Expression / drug effects
  • Histamine / pharmacology*
  • Histamine H1 Antagonists / pharmacology
  • Histamine H2 Antagonists / pharmacology
  • Humans
  • In Vitro Techniques
  • Interleukin-8 / genetics
  • Interleukin-8 / metabolism*
  • RNA, Messenger / genetics
  • Tumor Necrosis Factor-alpha / administration & dosage

Substances

  • Histamine H1 Antagonists
  • Histamine H2 Antagonists
  • Interleukin-8
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Histamine